As Gen AI continues to mature, there will be ways to employ these technologies thoughtfully and safely in healthcare today. The key is to continue to embrace new breakthroughs – with strong guardrails for safety, privacy and transparency. The post Eliminating the AI ‘Black Box’ to Make Clinical Data Usable appeared first on MedCity News.
Harnessing AI to Enhance Efficiency In Healthcare Technology Management Healthcare Technology Management (HTM) is evolving rapidly, and artificial intelligence (AI) is at the forefront of this transformation. By integrating AI into our CMMS, we’re exploring new ways to enhance operations, improve efficiency, and deliver better outcomes for healthcare facilities. These advancements reflect our dedication to…
CMS recently finalized the Patient Safety Structural Measure, which sets forth a broad roadmap for the implementation of a culture of safety, learning, transparency and accountability within hospitals and health systems nationwide — enabling and encouraging significant progress towards safer care and improved support for healthcare workers. The post Patient Safety Structural Measure Marks Progress…
Samantha Smith, de Harrisburg, Pennsylvania, entró al quirófano para la extracción de emergencia de un embarazo ectópico. “Estoy agradecida de no haber muerto”, dijo, pero se sorprendió al ver que la cirugía ambulatoria fue facturada a su aseguradora por unos $100.000. Jamie Estrada, de Albuquerque, Nuevo México, recibió en dos ocasiones inyecciones de lidocaína en…
Bristol Myers Squibb’s Opdualag paired with blockbuster immunotherapy Opdivo failed a clinical trial testing the regimen as an adjuvant therapy for patients whose melanoma has been surgically removed. While Opdualag is still projected to reach blockbuster status, it could face competition from a Regeneron Pharmaceuticals drug. The post Bristol Myers Squibb Cancer Immunotherapy Flunks a…
This fact sheet identifies key U.S. government global health positions and officials.
Site networks can play a pivotal role in aligning sponsors, sites, and investigators toward shared goals in oncology clinical trials, but they are not one-size-fits-all. Sponsors must carefully vet site networks to validate that they will deliver strategic value for each individual study. The post Redefining Clinical Oncology Trials: How Agile Site Networks Accelerate Novel Cancer…
[Sponsored] In an interview, Abarca Chief Information Officer Serge Perras discussed how Abarca is implementing AI and where he sees the most value for PBMs. The post AI Is at the Heart of PBM Evolution appeared first on MedCity News.
Rural health organizations cannot afford to get dazzled by AI demo candy. There is no such thing as “FixHealthcareGPT,” and investing in the wrong technology for the future isn’t going to do anything to improve patient outcomes today. The post Rural Healthcare Transformation Has to Focus on the Real World, Not Techno-Fantasies appeared first on…
To understand the impact of Medicaid work requirements included in the budget reconciliation bill being debated in Congress, KFF has undertaken two difference analyses using different data sources. Using 2023 data from the Survey of Income and Program Participation, this analysis looks at the share of adults who work at least 80 hours per month,…